STAT1-dependent and STAT1-independent gene expression in murine immune cells following stimulation with interferon-alpha
暂无分享,去创建一个
M. Radmacher | G. Lesinski | A. Ruppert | W. Carson | William E. Carson | J. Zimmerer | Gregory B. Lesinski | Jason M. Zimmerer | Michael D. Radmacher | Amy Ruppert
[1] E. Esplugues,et al. The Adaptor Protein 3BP2 Binds Human CD244 and Links this Receptor to Vav Signaling, ERK Activation, and NK Cell Killing1 , 2005, The Journal of Immunology.
[2] E. Borden,et al. IFN-alpha2b and thalidomide synergistically inhibit tumor-induced angiogenesis. , 2003, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.
[3] J. Ash,et al. Effect of Anti-CXCL10 Monoclonal Antibody on Herpes Simplex Virus Type 1 Keratitis and Retinal Infection , 2003, Journal of Virology.
[4] J. Kirkwood,et al. Interferon-alpha in tumor immunity and immunotherapy. , 2002, Cytokine & growth factor reviews.
[5] M. Grace,et al. Interferon-alpha as an immunotherapeutic protein. , 2002, Journal of leukocyte biology.
[6] M. Simon,et al. Granzymes are the essential downstream effector molecules for the control of primary virus infections by cytolytic leukocytes. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[7] Syed M. Rizvi,et al. Direct peptide-regulatable interactions between MHC class I molecules and tapasin , 2006, Proceedings of the National Academy of Sciences.
[8] G. Lesinski,et al. Multiparametric flow cytometric analysis of inter-patient variation in STAT1 phosphorylation following interferon Alfa immunotherapy. , 2004, Journal of the National Cancer Institute.
[9] A. Goldberg,et al. Rate of antigen degradation by the ubiquitin-proteasome pathway influences MHC class I presentation. , 1995, Journal of immunology.
[10] F. Belardelli,et al. Antitumor effects of interferon in mice injected with interferon‐sensitive and interferon‐resistant friend leukemia cells. I. , 1982, International journal of cancer.
[11] Richard M. Ransohoff,et al. Stat1-independent regulation of gene expression in response to IFN-γ , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[12] P. Rubegni,et al. Different effects of interferon‐α on melanoma cell lines: a study on telomerase reverse transcriptase, telomerase activity and apoptosis , 2003, The British journal of dermatology.
[13] E. Usherwood,et al. CD80 and CD86 Control Antiviral CD8+ T-Cell Function and Immune Surveillance of Murine Gammaherpesvirus 68 , 2006, Journal of Virology.
[14] S. Jalkanen,et al. Ly6C Induces Clustering of LFA-1 (CD11a/CD18) and Is Involved in Subtype-Specific Adhesion of CD8 T Cells 1 , 2003, The Journal of Immunology.
[15] U. Wahn,et al. Effects of interferon‐α on cytokine profile, T cell receptor repertoire and peptide reactivity of human allergen‐specific T cells , 1996, European journal of immunology.
[16] G. Lesinski,et al. The antitumor effects of IFN-α are abrogated in a STAT1-deficient mouse , 2003 .
[17] G. Lesinski,et al. IFN-α-Induced Signal Transduction, Gene Expression, and Antitumor Activity of Immune Effector Cells Are Negatively Regulated by Suppressor of Cytokine Signaling Proteins1 , 2007, The Journal of Immunology.
[18] D. Levy,et al. Targeted Disruption of the Mouse Stat1 Gene Results in Compromised Innate Immunity to Viral Disease , 1996, Cell.
[19] D. Jukic,et al. Neoadjuvant treatment of regional stage IIIB melanoma with high-dose interferon alfa-2b induces objective tumor regression in association with modulation of tumor infiltrating host cellular immune responses. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[20] E. Borden,et al. IFN-α2b and thalidomide synergistically inhibit tumor-induced angiogenesis , 2003 .
[21] F. Fallarino,et al. Stat 1 CTL In Vivo Requires Host Expression of Cutting Edge : Differentiation of Antitumor , 1999 .
[22] B. Bisikirska,et al. Gene expression profiling and functional activity of human dendritic cells induced with IFN-alpha-2b: implications for cancer immunotherapy. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.
[23] A. Frey. Myeloid suppressor cells regulate the adaptive immune response to cancer. , 2006, The Journal of clinical investigation.
[24] G. Lesinski,et al. The antitumor effects of interferon-alpha are maintained in mice challenged with a STAT1-deficient murine melanoma cell line. , 2004, The Journal of surgical research.
[25] J. Darnell,et al. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. , 1994, Science.
[26] B. Williams,et al. Signal transduction in the interferon system. , 1998, Seminars in oncology.
[27] F. Belardelli,et al. Anti‐tumor effects of interferon in mice injected with interferon‐sensitive and interferon‐resistant friend erythroleukemia cells. VIII. Role of the immune system in the inhibition of visceral metastases , 1990, International journal of cancer.
[28] C. Biron. Interferons α and β as Immune Regulators—A New Look , 2001 .
[29] Chilakamarti V. Ramana,et al. Biologic consequences of Stat1-independent IFN signaling , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[30] C. Garbe,et al. Antitumor activities of interferon alpha, beta, and gamma and their combinations on human melanoma cells in vitro: changes of proliferation, melanin synthesis, and immunophenotype. , 1990, The Journal of investigative dermatology.
[31] F. Belardelli,et al. Antitumor effects of interferon in mice injected with interferon‐sensitive and interferon‐resistant friend leukemia cells. II. Role of host mechanisms , 1982, International journal of cancer.
[32] M. Atkins,et al. Autoimmunity and immunotherapy for cancer. , 2006, The New England journal of medicine.
[33] S. Hedrick,et al. A Pivotal Role for the Multifunctional Calcium/Calmodulin-Dependent Protein Kinase II in T Cells: From Activation to Unresponsiveness1 , 2005, The Journal of Immunology.
[34] Tetsuo Nakamura,et al. Correlation between expression of major histocompatibility complex class I and that of antigen presenting machineries in carcinoma cell lines of the pancreas, biliary tract and colon. , 2006, The Kobe journal of medical sciences.
[35] F. Belardelli,et al. Interaction of IFN α/β with host cells essential to the early inhibition of friend erythroleukemia visceral metastases in mice , 1994 .
[36] C. Biron. Interferons alpha and beta as immune regulators--a new look. , 2001, Immunity.
[37] M. Grace,et al. Interferon‐α as an immunotherapeutic protein , 2002, Journal of Leukocyte Biology.
[38] J. Darnell,et al. Transcriptional regulation of interferon-stimulated genes: a DNA response element and induced proteins that recognize it. , 1988, Cold Spring Harbor symposia on quantitative biology.
[39] Cheng Li,et al. DNA-Chip Analyzer (dChip) , 2003 .